InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $2.040 0.01 (0.49%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$731 Results of Meeting 29 Aug 2024 11:37AM $0.495 $2.040 risen by 312.12%
$731 H1 FY24 Results Investor Presentation 28 Aug 2024 8:10AM $0.520 $2.040 risen by 292.31%
$731 Imricor releases Half Year Results for 1H 2024 28 Aug 2024 8:09AM $0.520 $2.040 risen by 292.31%
$731 Appendix 4D and Half Year Report & Accounts 28 Aug 2024 8:08AM $0.520 $2.040 risen by 292.31%
$731 Imricor Pauses TGA Process to Wait for 2nd Gen Catheter 13 Aug 2024 8:16AM $0.530 $2.040 risen by 284.91%
$731 Notice of Extraordinary General Meeting/Proxy Form 8 Aug 2024 5:04PM $0.530 $2.040 risen by 284.91%
$731 Release from Voluntary Escrow 8 Aug 2024 4:52PM $0.530 $2.040 risen by 284.91%
$731 FY24 1H Results Webinar Notification 8 Aug 2024 4:32PM $0.530 $2.040 risen by 284.91%
$731 First Patient Treatment in the U.S. in the VISABL-AFL Trial 7 Aug 2024 9:08AM $0.523 $2.040 risen by 290.43%
$731 Appendix 3X - Jeffrey Leighton 6 Aug 2024 12:42PM $0.528 $2.040 risen by 286.73%
$731 Ceasing to be a substantial holder 31 Jul 2024 9:23AM $0.580 $2.040 risen by 251.72%
$731 Imricor Q2 CY24 Quarterly Activities Report and Appendix 4C 31 Jul 2024 9:13AM $0.580 $2.040 risen by 251.72%
$731 Cleansing Notice 26 Jul 2024 3:15PM $0.580 $2.040 risen by 251.72%
$731 Application for quotation of securities - IMR 26 Jul 2024 11:55AM $0.535 $2.040 risen by 281.31%
$731 Proposed issue of securities - IMR 19 Jul 2024 10:21AM $0.590 $2.040 risen by 245.76%
$731 Equity Raising Presentation 19 Jul 2024 10:21AM $0.590 $2.040 risen by 245.76%
$731 Imricor Successfully Raises A$35 Million via Placement 19 Jul 2024 10:21AM $0.590 $2.040 risen by 245.76%
$731 Trading Halt 17 Jul 2024 9:29AM $0.590 $2.040 risen by 245.76%
$731 Release from Voluntary Escrow 16 Jul 2024 9:06AM $0.598 $2.040 risen by 241.42%
$731 Imricor Completes Capital Equipment Installation at CHUV 1 Jul 2024 9:45AM $0.530 $2.040 risen by 284.91%
$731 Successful Completion of Second Case by Dubrava 28 Jun 2024 9:42AM $0.495 $2.040 risen by 312.12%
$731 Imricor Wins New Customer in Hungary 26 Jun 2024 9:03AM $0.475 $2.040 risen by 329.47%
$731 Imricor Commences VISABL-AFL Trial for US FDA Approval 21 Jun 2024 9:10AM $0.415 $2.040 risen by 391.57%
$731 Commencement of Procedures at Dubrava University Hospital 20 Jun 2024 9:43AM $0.415 $2.040 risen by 391.57%
$731 Notification of cessation of securities - IMR 13 Jun 2024 9:05AM $0.435 $2.040 risen by 368.97%

151 - 175 of 596 results

Page 7 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.